SK Bioscience Co Ltd (302440) — Free Cash Flow Generation Index
SK Bioscience Co Ltd (302440) has a Free Cash Flow Generation Index of -2.44x as of September 2025. Free cash flow of ₩-50.29 Billion represents -2% of operating cash flow (₩20.65 Billion). Explore 302440 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SK Bioscience Co Ltd Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for SK Bioscience Co Ltd across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of SK Bioscience Co Ltd.
Annual Free Cash Flow Generation for SK Bioscience Co Ltd (2018–2023)
Year-by-year Free Cash Flow Generation Index for SK Bioscience Co Ltd. Check total reinvestment intensity of SK Bioscience Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.71x | ₩-20.95 Billion | ₩29.35 Billion | ₩50.30 Billion | ▼ -177.8% |
| 2021 | 0.92x | ₩492.12 Billion | ₩536.59 Billion | ₩42.91 Billion | ▲ +0.2% |
| 2020 | 0.92x | ₩110.03 Billion | ₩120.22 Billion | ₩9.93 Billion | ▲ +594.7% |
| 2019 | -0.19x | ₩-4.04 Billion | ₩21.82 Billion | ₩23.97 Billion | ▼ -132.1% |
| 2018 | 0.58x | ₩8.59 Billion | ₩14.90 Billion | ₩6.31 Billion | — |